Iambic Therapeutics, Inc. (IAM) stock
IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$15.38+0.61 (+4.09%)
Close on Nov 11, 2026Market cap –P/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Trading
- Previous close
- $14.78
- Open
- $14.87
- Day's range
- $13.96 – $15.85
- Volume
- 364,830
- Average volume (20 days)
- 833,646
Iambic Therapeutics stock: common questions
What is Iambic Therapeutics's stock price?
IAM closed at $15.38 on Nov 11, 2026, up 4.09% on the day.
Does Iambic Therapeutics pay a dividend?
No. Iambic Therapeutics has not paid a cash dividend over the last twelve months.
Who are Iambic Therapeutics's competitors?
Companies most similar to Iambic Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?